AIDS Home > Viread and Pregnancy
It is not fully known whether Viread and pregnancy is a safe combination. When the drug was given to pregnant animals, it did not cause birth defects or miscarriages. However, animals do not always respond to medications the same way that humans do, so if you are taking Viread and pregnancy occurs, your healthcare provider will consider the benefits and risks in your particular situation.
Viread® (tenofovir disoproxil fumarate) is a prescription hepatitis B and HIV treatment. Because it has not been adequately studied in pregnant women, it is not known if Viread is safe for use during pregnancy. However, in some circumstances, the benefits of the drug may outweigh the potential risks.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is given to medicines that have not been studied in pregnant humans but that do not appear to cause harm to the fetus in animal studies. When given to pregnant animals, Viread did not increase the risk of miscarriages or birth defects.
However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if her healthcare provider believes that the benefits for the mother outweigh any possible risks to the unborn child.
If you are pregnant, it is always a good idea to ask your healthcare provider before taking any medication. You and your healthcare provider can consider the possible risks and benefits of using Viread in your particular situation, as well as any other treatment alternatives. Women with HIV need special prenatal care, both for themselves and to prevent the transmission of HIV to their babies.